S K Biobiz Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-07-2024
- Paid Up Capital ₹ 0.10 M
as on 05-07-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 M
as on 05-07-2024
- Revenue 96.77%
(FY 2021)
- Profit 121.25%
(FY 2021)
- Ebitda 120.26%
(FY 2021)
- Net Worth 111.33%
(FY 2021)
- Total Assets 144.59%
(FY 2021)
About S K Biobiz
The Company is engaged in the Life Science Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.00 M.
Parag Saudagar and Nimesh Karpe serve as directors at the Company.
- CIN/LLPIN
U01403MH2015PTC269601
- Company No.
269601
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Oct 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does S K Biobiz Private Limited offer?
S K Biobiz Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Fertilizer, Insecticides and Pesticides, Bio Insecticides, Bio Fertilizers, Bird Food, Poultry & Animal Food, Feed Additives, Animal Feed Supplement, Biofungicides, Plant Growth Promoters.
Who are the key members and board of directors at S K Biobiz?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parag Saudagar  | Director | 26-Oct-2015 | Current |
| Nimesh Karpe | Director | 26-Oct-2015 | Current |
Financial Performance of S K Biobiz.
S K Biobiz Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 96.77% increase. The company also saw a substantial improvement in profitability, with a 121.25% increase in profit. The company's net worth Soared by an impressive increase of 111.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of S K Biobiz?
In 2021, S K Biobiz had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sk Biobiz Foodtech Private LimitedActive 2 years 6 monthsParag Saudagar and Nimesh Karpe are mutual person
- Sk Biobiz Agro Private LimitedActive 4 years 10 months
Parag Saudagar and Nimesh Karpe are mutual person
Mediclerx Healthcare Solutions Private LimitedActive 2 years 9 monthsNimesh Karpe is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 11 Jun 2021 | ₹1.50 M | Open |
Canara Bank Creation Date: 11 Jun 2021 | ₹4.50 M | Open |
How Many Employees Work at S K Biobiz?
S K Biobiz has a workforce of 30 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S K Biobiz, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S K Biobiz's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
